Our world is facing recurrent waves of coronavirus disease 2019 (COVID-19) with the emergence of more infectious strains of the novel coronavirus, SARS-CoV-2. Multiple studies have established that heart failure (HF) patients are at high risk of severe disease and poor outcomes with COVID-19. Management of COVID-19 in patients with HF, heart transplant, and those supported with durable left ventricular assist devices present an arduous challenge due to underlying complex health conditions and overlap of symptoms. Based on available data, this review outlines the management of this vulnerable patient population who either present with COVID-19 with preexisting HF or with de novo HF from COVID-19.
All Keywords
【저자키워드】 COVID-19, heart failure, heart transplant, Left ventricular assist device, 【초록키워드】 coronavirus disease, SARS-CoV-2, outcome, Symptoms, Novel coronavirus, management, Patient, strain, severe disease, high risk, available data, overlap, complex, Multiple, patient population, de novo, health condition, supported, assist, COVID-19 in patient, ventricular, with COVID-19, 【제목키워드】 Transplant, heart, Device, failure, left,
【저자키워드】 COVID-19, heart failure, heart transplant, Left ventricular assist device, 【초록키워드】 coronavirus disease, SARS-CoV-2, outcome, Symptoms, Novel coronavirus, management, Patient, strain, severe disease, high risk, available data, overlap, complex, Multiple, patient population, de novo, health condition, supported, assist, COVID-19 in patient, ventricular, with COVID-19, 【제목키워드】 Transplant, heart, Device, failure, left,